心理社会疼痛管理干预对物质使用障碍合并慢性疼痛患者的疗效:随机临床试验
本随机临床试验纳入510名接受住院物质使用障碍治疗的成人,比较8次整合行为疼痛管理干预(ImPAT)与8次支持性心理教育对照(SPC)的疗效。12个月随访显示,ImPAT与男性疼痛耐受性提高相关,与女性疼痛强度降低相关,但两组在酒精或药物使用频率上无差异。
要点
- ImPAT与SPC在12个月酒精或药物使用频率上无差异。
核心结论
- 行为疼痛管理干预与更好的疼痛相关结局相关,包括男性疼痛耐受性和女性疼痛强度。
- 未观察到物质使用相关结局优于常规治疗的改善。
研究设计与样本
- 随机临床试验,比较8次ImPAT与8次SPC,在大型住院物质使用障碍治疗项目中开展。
- 筛查1372名成人(960名男性、412名女性),随机510名(264名男性、246名女性),470名(92.2%)完成至少一次随访。
- 随访在基线后3、6、12个月进行;数据收集于2011年10月3日至2016年1月14日,分析于2016年2月1日至2020年5月1日。
主要发现
- ImPAT与SPC在12个月酒精或药物使用频率上无差异。
临床怎么用
- 治疗项目应考虑提供心理社会疼痛管理服务以增强标准成瘾治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Chronic pain is common in those with substance use disorders (SUDs) and predicts poorer addiction treatment outcomes. A critical challenge for addiction treatment is to develop effective methods to improve pain-related and substance use-related outcomes for those in treatment for SUDs. OBJECTIVE: To examine the efficacy of an integrated behavioral pain management intervention (Improving Pain During Addiction Treatment [ImPAT]) for men and women with SUDs to treat pain, functioning, and substance use. DESIGN, SETTING, AND PARTICIPANTS: In this randomized clinical trial, 8 sessions of ImPAT were compared with 8 sessions of a supportive psychoeducational control (SPC) condition for adults with pain treated at a large residential SUD treatment program. Follow-up occurred at 3, 6, and 12 months postbaseline. A total of 1372 adults were screened, including 960 men and 412 women, and 510 adults were randomized, including 264 men and 246 women. The goal was to recruit approximately equal numbers of men and women to examine results separately in men and women. A total of 470 of 510 participants (92.2%) completed at least 1 follow-up assessment. Data were collected from October 3, 2011, to January 14, 2016. Data were analyzed from February 1, 2016, to May 1, 2020. INTERVENTIONS: ImPAT focused on how a psychosocial model of pain was associated with functioning and relapse prevention and provides skills to manage pain. SPC served as the active control condition and involved discussions of topics like nutrition and the course of addiction, which were intended to be relevant to the patient population and to have face validity but be distinct from the content of ImPAT. MAIN OUTCOMES AND MEASUREMENTS: The primary outcomes were pain intensity, pain-related functioning, and behavioral pain tolerance at 12 months. Secondary outcomes were frequency of alcohol and drug use over 12 months. RESULTS: Of the 510 included participants, the mean (SD) age was 34.8 (10.3) years. A total of 133 men and 122 women were assigned to ImPAT, and a total of 131 men and 124 women were assigned to the SPC condition. Over 12 months of follow-up, randomization to the ImPAT intervention was associated with higher tolerance of pain among men, higher by a mean score of 0.11 (95% CI, 0.03 to 0.18; P = .004; Cohen d = 0.40) at 3 months and by 0.07 (95% CI, -0.01 to 0.19; P = .11; Cohen d = 0.25) at 12 months. Women receiving the ImPAT intervention experienced a reduction in pain intensity from 3 to 12 months, while women receiving the SPC condition experienced an increase in pain intensity, resulting in lower pain in the ImPAT condition by a mean score of 0.58 (95% CI, -0.07 to 1.22; P = .08; Cohen d = -0.22) at 12 months. No differences were found between the ImPAT and SPC conditions on alcohol or drug use. CONCLUSIONS AND RELEVANCE: Behavioral pain management is not typically included in addiction treatment, but the present results indicate that this type of intervention was associated with better pain-related outcomes, including pain tolerance in men and pain intensity in women. Improvements in substance use-related outcomes beyond that achieved by treatment as usual were not observed. Treatment programs should consider providing psychosocial pain management services to augment standard addiction treatment. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01372267.
引用
- Ilgen MA, Coughlin LN, Bohnert ASB, et al. Efficacy of a Psychosocial Pain Management Intervention for Men and Women With Substance Use Disorders and Chronic Pain: A Randomized Clinical Trial. JAMA Psychiatry. 2020. PMID: 32725178. doi:10.1001/jamapsychiatry.2020.2369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。